|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 36975 |
FusionGeneSummary for SYT16_MNAT1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: SYT16_MNAT1 | Fusion gene ID: 36975 | Hgene | Tgene | Gene symbol | SYT16 | MNAT1 | Gene ID | 83851 | 4331 |
| Gene name | synaptotagmin 16 | MNAT1, CDK activating kinase assembly factor | |
| Synonyms | CHR14SYT|SYT14L|Strep14|syt14r|yt14r | CAP35|MAT1|RNF66|TFB3 | |
| Cytomap | 14q23.2 | 14q23.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | synaptotagmin-16CTD-2277K2.1chr14 synaptotagminsynaptotagmin 14-like proteinsynaptotagmin XIV-related proteinsynaptotagmin XVI | CDK-activating kinase assembly factor MAT1CDK7/cyclin-H assembly factorMNAT CDK-activating kinase assembly factor 1RING finger protein 66RING finger protein MAT1cyclin G1 interacting proteinmenage a trois 1 (CAK assembly factor)menage a trois homol | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | Q17RD7 | P51948 | |
| Ensembl transtripts involved in fusion gene | ENST00000446982, ENST00000430451, | ENST00000555545, ENST00000261245, ENST00000539616, | |
| Fusion gene scores | * DoF score | 2 X 2 X 2=8 | 9 X 6 X 5=270 |
| # samples | 2 | 10 | |
| ** MAII score | log2(2/8*10)=1.32192809488736 | log2(10/270*10)=-1.43295940727611 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: SYT16 [Title/Abstract] AND MNAT1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | MNAT1 | GO:0006357 | regulation of transcription by RNA polymerase II | 10801852 |
| Tgene | MNAT1 | GO:0006366 | transcription by RNA polymerase II | 9852112 |
| Tgene | MNAT1 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 8692841 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | BLCA | TCGA-GV-A3QI-01A | SYT16 | chr14 | 62437029 | + | MNAT1 | chr14 | 61346432 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-intron | ENST00000446982 | ENST00000555545 | SYT16 | chr14 | 62437029 | + | MNAT1 | chr14 | 61346432 | + |
| intron-intron | ENST00000446982 | ENST00000261245 | SYT16 | chr14 | 62437029 | + | MNAT1 | chr14 | 61346432 | + |
| intron-intron | ENST00000446982 | ENST00000539616 | SYT16 | chr14 | 62437029 | + | MNAT1 | chr14 | 61346432 | + |
| intron-intron | ENST00000430451 | ENST00000555545 | SYT16 | chr14 | 62437029 | + | MNAT1 | chr14 | 61346432 | + |
| intron-intron | ENST00000430451 | ENST00000261245 | SYT16 | chr14 | 62437029 | + | MNAT1 | chr14 | 61346432 | + |
| intron-intron | ENST00000430451 | ENST00000539616 | SYT16 | chr14 | 62437029 | + | MNAT1 | chr14 | 61346432 | + |
Top |
FusionProtFeatures for SYT16_MNAT1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| SYT16 | MNAT1 |
| May be involved in the trafficking and exocytosis ofsecretory vesicles in non-neuronal tissues. Is Ca(2+)-independent. | Stabilizes the cyclin H-CDK7 complex to form afunctional CDK-activating kinase (CAK) enzymatic complex. CAKactivates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6by threonine phosphorylation. CAK complexed to the core-TFIIHbasal transcription factor activates RNA polymerase II by serinephosphorylation of the repetitive C-terminal domain (CTD) of itslarge subunit (POLR2A), allowing its escape from the promoter andelongation of the transcripts. Involved in cell cycle control andin RNA transcription by RNA polymerase II.{ECO:0000269|PubMed:10024882}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for SYT16_MNAT1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for SYT16_MNAT1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| SYT16 | SYT16, SYT14, PHC2, ZBTB14, RABAC1, AGTRAP, RTN4, NCOA5, SEMG2, SEMG1, DUSP14, DSG4, PKP3, HIST1H1B, SERPINB5, LRRC15, SELENBP1 | MNAT1 | CCNH, ERCC3, MTA1, ESR1, CDK7, HPS6, COPS6, RBM48, EEF1A1, LRIF1, POU5F1, POU2F2, POU2F1, MCM7, RB1, TP53, DMAP1, GTF2H2, GTF2H1, SP1, ERCC2, XBP1P1, ICK, BRCA1, GTF2H3, GTF2H4, USP2, POLR2A, SUPT5H, NKX3-1, TRIM2, TRIM9, TRIML1, MKRN3, TRIM31, TRIM34, RNF32, TRIM17, RNF7, RNF41, TRIM21, TRIM39, TRIM5, MDM4, TRIM26, NGFRAP1, RPA3, RPA2, RPA1, CDK2, SFR1, HIST1H2BG, PCIF1, GTF2H5, MAGEC2, MAGEE2, SIRT6 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SYT16_MNAT1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for SYT16_MNAT1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|